OBJECTIVES: Recently, lung segmental resection has been increasingly performed in patients with lung cancer. In this study, the results of radical segmentectomy (RS) and palliative segmentectomy (PS) were compared retrospectively.
INTRODUCTION
Because it is essential to minimize the volume of lung resection without diminishing curability, curative segmentectomy to treat non-small-cell primary lung cancer has been attracting attention [1] [2] [3] [4] . Therefore, lung segmental resection has been increasingly performed. For non-small-cell primary lung cancer, we tried segmentectomy for cases with adequate lung function for lobectomy. Segmentectomy was intensively performed as radical segmentectomy (RS) in lung cancer cases with pure ground-glass opacity (GGO) or with more than 50% GGO and less than 2 cm diameter. It was also performed as palliative segmentectomy (PS) in cases with low lung function, relapse or high-risk conditions. In this study, the feasibility of segmentectomy for lung cancer with GGO was investigated retrospectively by comparing RS and PS cases.
MATERIALS AND METHODS
Of 151 patients who underwent segmentectomy for primary lung cancer, metastatic lung cancer or inflammatory lung disease from 2003 to 2013 (82 men, 64 women; mean age, 65.4 ± 12.1 years), video-assisted thoracoscopic surgery (VATS) segmentectomy (complete VATS and hybrid VATS) was performed in 100 patients (66.2%). Segmentectomy was performed to remove a non-small-cell primary lung cancer in 87 patients; 84 cases, excluding 3 relapsed cases, of RS were investigated.
The intersegmental plane was identified with our original method [5] . Briefly, in our surgical procedure, the segmental pulmonary artery and vein were cut. The segment was then inflated with pure oxygen for 5 min. Immediately after oxygen inflation, the segmental bronchus was deflated and stapled. After a couple of minutes, the intersegmental plane was easily detected. A stapler or electrocauterization was used along this plane for the segmental resection.
Segmentectomy was performed as RS in lung cancer cases with pure GGO, more than 50% GGO and less than 2 cm in diameter, and less than 10 mm solid tumours, or as part of a Japanese clinical study (the Japan Clinical Oncology Group/West Japan Oncology Group ( JCOG0802/WJOG4607L)) [6] . The sizes of solid attenuation and GGO were evaluated radiologically [7] . In cases with low lung function or a high-risk condition, PS was performed. RS was performed in 34 patients, and PS was performed in 50 cases with hilar or mediastinal lymph node resection. There were 72 patients in pathological stage I (RS: 34 cases and PS: 38 cases). Surgical complete resection was performed in PS, not including noncurative resection. Overall survival (OS) of pathological stage I cases was examined, and OS and disease-free survival (DFS) of pathological stage I RS and PS were compared.
Statistical analysis
The χ 2 test was used to compare categorical variable frequencies. Fisher's exact test was used when sample sizes were small. OS was defined as the time from the date of surgery until death due to any cause or the last follow-up. DFS was defined as the time from the date of surgery until the first event (relapse or death due to any cause) or the last follow-up. The Kaplan-Meier method was used to assess DFS and OS durations, and these were compared using log-rank tests. The SPSS software (version 19; SPSS, Inc., Chicago, IL, USA) was used for statistical analysis. The level of significance was set at P < 0.050.
RESULTS
The patient characteristics are given in Table 1 . Of the 84 patients with a non-small-cell primary lung cancer, 45 were women and 39 were men, with a mean age of 70.4 ± 9.6 years. Tumour size ranged from 3 to 40 mm (mean size 18.4 ± 7.9 mm). Histologically, there were 64 adenocarcinomas (76.1%), 16 squamous cell carcinomas (19.0%), 2 large-cell neuroendocrine carcinomas (2.4%), 1 large-cell carcinoma (1.2%) and 1 pleomorphic carcinoma (1.2%). Pathological examination showed that curative resections were achieved with free surgical margins in all the patients. Postoperative complications were prolonged air leakage for more than 7 postoperative days in 10 (11.9%), late alveolar fistula occurring after removal of the chest tube in 4 (4.8%), pneumonia in 5 (6.0%), atelectasis in 5 (6.0%), arrhythmia in 4 (4.8%), chylothorax in 1 (1.2%) and other in 2 (2.4%). The pathological stage of RS was IA in 32 (94.1%) and IB in 2 (5.9%). The pathological stage of PS was IA in 23 (46.0%), IB in 15 (30.0%), IIA in 5 (10.0%), IIB in 1 (2.0%), IIIA in 4 (8.0%) and IV in 2 (4.0%). The operative indications for RS were tumour with GGO in 28 (82.4%), which consisted of 100% GGO in 16 cases (47.1%), more than 75% GGO in 3 (8.8%), more than 50% GGO in 9 (26.5%), solid tumour less than 10 mm in 5 (14.7%) and 1 (2.9%) case in a Japanese clinical study. Table 2 provides the locations of the affected segments.
The preoperative characteristics of RS cases were compared with those of PS cases of pathological stage I (Table 3) , because all RS cases were classified as pathological stage I. The mean age was significantly lower for RS cases (67.4 ± 9.9 years) than for PS cases (73.0 ± 9.0 years; P = 0.013). Tumour size was significantly smaller in RS cases (14.7 ± 4.6 mm) than in PS cases (22.0 ± 8.9 mm; P < 0.001). The tumour standardized uptake value (SUV) of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) was significantly lower in RS cases (1.2 ± 1.6) than in PS cases (6.0 ± 6.1; P < 0.001). Serum carcinoembryonic antigen (CEA) level was significantly lower in RS cases (2.8 ± 1.8 ng/ml) than in PS cases (4.9 ± 5.0; P = 0.019). The tumour was located peripherally at the outer one-third in significantly more RS (32 cases (94.1%)) than PS (22 cases (57.9%); P < 0.001) cases. With respect to 2 cases with central RS, the tumour of 1 case was 10 mm in diameter and was located in the left lower superior segment (S6), while the other one was a 12-mm pure GGO tumour located in the left lower anterior basal segment (S8). These cases underwent S6 segmentectomy and S8 + 9 segmentectomy, respectively.
The VATS procedure was used more often in RS than in PS (Table 4) . Adenocarcinoma was more common in RS (33 cases (97.1%)) than in PS (27 cases (71.1%); P = 0.003). The mean duration of drainage was shorter in RS (2.5 ± 0.7 days) than in PS (3.9 ± 2.6 days; P = 0.004). Postoperative complications related to the operative procedures occurred in 6 RS cases (17.6%), including late alveolar fistula in 4 (11.8%) and atelectasis in 2 (5.9%). Postoperative complications related to the operative procedures occurred in 12 PS cases (31.6%), including prolonged air leak in 5 (13.2%), atelectasis in 3 (7.9%) and pneumonia in 5 (13.2%).
The follow-up was performed every 6 months for 5 years after the operation, with haematological examinations and chest computed tomographic scans performed every year. The patients were followed up for 5-119 months (mean, 34.6 months). Overall 5-year survival rates of pathological stage I (n = 72) and tumour less than 2 cm (n = 52) of pathological stage I were 83.0 and 91.2%, respectively (Fig. 1) . Overall 5-year survival was higher in RS (100.0%) than in PS (66.2%; log-rank P = 0.003) (Fig. 2) . Five-year DFS was higher in RS (100.0%) than in PS (66.2%; log-rank P = 0.002). Recurrence was detected in 6 PS patients, including 1 case of ipsilateral mediastinal lymph node recurrence and 5 cases of distant metastasis. Eight patients died: 5 from cancer recurrence and 3 from other cause. Ten PS cases showed tumour with GGO and survived without recurrence.
DISCUSSION
Recently, segmental resection has been performed frequently for early lung cancer or metastatic lung tumour [1] [2] [3] [4] . The Lung Cancer Study Group demonstrated that sublobar resections, including wedge resections, resulted in a local recurrence rate three times higher than that of lobectomy in patients with clinical T1N0M0 non-small cell lung cancer (NSCLC) in their randomized study [8] . However, sublobar resection for NSCLC is indicated for a small lung cancer less than 2 cm in diameter [3, 9, 10] . In addition, clinical trials to compare surgical results between lobectomy and segmentectomy for clinical T1aN0M0 NSCLC have started registration of cases by the Japan Clinical Oncology Group/West Japan Oncology Group ( JCOG0802/WJOG4607L) [6] . The Cancer and Leukemia Group B (CALGB140503) et al. [11] conducted clinical trials to compare surgical results between lobectomy and sublobar resection (segmentectomy or wedge resection) for clinical T1aN0M0. In the present study, the tumour size of RS cases was 15 ± 5 mm (range 6-25 mm). Only two 25-mm tumours (>20 mm diameter) showed 80 and 100% GGO. Noguchi et al. [12] demonstrated that localized bronchioloalveolar carcinoma (LBAC) showed replacement growth of alveolar-lining epithelial cells with a relatively thin stroma, and LBAC with foci of structural collapse of alveoli were in situ peripheral adenocarcinoma, and lung cancer patients with these LABCs achieved 100% survival after lobectomy. Several authors have reported that lung cancers containing LBAC showing GGO features radiologically have a good prognosis and could be candidates for sublobar resection instead of standard lobectomy [7, 13, 14] . Tsutani et al. [15] demonstrated that GGO-dominant clinical stage IA lung adenocarcinomas were tumours that exhibit lowgrade malignancy for which wedge resection or segmentectomy can be done. In the present study, the 28 GGO-dominant cases of RS and the 10 PS cases survived without recurrence.
In the present study, the clinical features of RS cases were compared with those of pathological stage I PS cases. The PS cases were selected for the segmental procedure based on low lung function, relapse, or a high-risk condition, rather than on the radiological features of the tumour, whereas the RS cases were selected based on specific indications such as pure GGO, more than 50% GGO and less than 2 cm in diameter, less than 10 mm solid tumour, or as part of a Japanese clinical study. The RS lung cancer cases were younger, had smaller lower tumour size, lower SUV on FDG-PET and more often a peripherally located tumour than the PS cases. Okada et al. [16] demonstrated that SUVmax was a significant preoperative predictor for surgical outcomes. They showed an optimal SUV cut-off value to predict high-grade malignancy of 2.5. Hattori et al. [17] showed that SUVmax was a significant predictor of lymph node involvement. In the present study, SUV was 1.2 ± 1.6 in RS and 5.9 ± 6 in PS. All of the present RS cases were classified as pathological stage I without lymph node metastasis.
As a specific complication related to segmental resection, late alveolar fistula was observed in 4 cases (11.8%) in RS. Electrocauterization was used for intersegmental plane resection in late alveolar fistula cases. In addition, prolonged air leak was observed in 5 cases (12.1%) of PS. Okada et al. [18] reported 2 (3.8%) late alveolar fistulas and 4 (7.7%) prolonged air leaks in 52 cases of segmental resection.
We identified the intersegmental plane using our method [5] . In the present 151 cases of segmental resection, only 1 (0.7%) case required reoperation to close the fistula after right upper segmentectomy of the lower lobe for metastatic lung cancer. Therefore, even though late alveolar fistula and prolonged air leak were more frequent in segmental resection, we think they are acceptable complications.
Conversely, local recurrence that occurs in the residual lobe, such as surgical margin recurrence, is a serious problem for radical segmental resection. Completion lobectomy is required in this situation. Sawabata [19] demonstrated the importance of the surgical margin when the ratio of the margin distance/tumour size was greater than 1. Ueda et al. [20] showed the safety anatomical margin for segmentectomy using a computed tomography (CT)-based simulation technique. Therefore, achieving anatomical segmental resection requires profound knowledge of the bronchovascular structure. While no surgical margin recurrence case of RS was observed, we had 1 case of PS that occurred after left lower superior segmentectomy after left upper lobectomy. In this case, local radiation was performed to avoid completion pneumonectomy. We think radical segmental resection should be performed with the utmost care and attention. Tumours were significantly more often located peripherally in the outer one-third in RS than in PS. We think that most RS cases were selected for the reason that it was easy to perform a successful segmental resection technically with a peripheral tumour location. Recently, as minimally invasive surgery, VATS segmentectomy is considered an ideal surgical procedure to treat primary lung cancer [21] . D'Amico [22] reported the technical considerations and outcomes of VATS segmentectomy. Yang and D'Amico [23] showed that thoracoscopic segmentectomy was feasible and safe and achieved equivalent oncological results compared with open segmentectomy. Okada et al. [18] demonstrated hybrid VATS segmentectomy, using a monitor as well as direct visualization. Their hybrid VATS method seems to be reasonable with respect to the tumour surgical margin issue for VATS segmentectomy. In the present study, hybrid VATS segmentectomy was performed in almost all VATS cases ( Table 4 ).
The present study had some limitations, as it was a singleinstitution study that involved a small number of cases. Nevertheless, several papers have reported that lung cancer with GGO had a good prognosis, but our follow-up duration was short (mean, 34.6 months). In addition, 100% GGO accounted for 47.1% of RS in the present study, which may have affected the outcome.
In conclusion, RS is feasible for stage I lung cancer with features of pure GGO, more than 50% GGO and diameter less than 2 cm, or a less than 10 mm diameter solid tumour, located peripherally to maintain the anatomical surgical margin.
APPENDIX. CONFERENCE DISCUSSION
Dr K. Athanassiadi (Athens, Greece): I would like to ask one practical question. I like the technique. It was nice to see your video also; I really admire these kind of techniques. I didn't really understand the objective of the study. I mean if you have a case like that, if you have stage I, ground-glass opacity, it is normal that you can do a radical segmentectomy.
Dr Iwata: With a patient under informed consent, we try to do radical segmentectomy to cure the lung cancer.
Dr Athanassiadi: Yes, but still, in these kind of cases, stage I, ground-glass opacity, it is easy because it is small, and you can have it not as a palliative but as a radical, as you mean it, although with the term "radical segmentectomy", there is a lot to discuss.
Dr Iwata: This term? Dr Athanassiadi: Yes, this term, the term "radical segmentectomy." There is no radical and non-radical segmentectomy; it is segmentectomy, if we want to use the same language among us.
Dr Iwata: Yes, I agree with you on that. We have to consider the definition of radical segmentectomy regarding a curing segmentectomy.
Dr Athanassiadi: Curative segmentectomy? Dr Iwata: Yes, curative segmentectomy, yes, compared to the palliative. Dr M. Dusmet (London, UK): Just in addition to what Kalliopi was saying, as a comment, I would just like to remind the audience what we discussed on Saturday. I completely agree with what you are saying, Kalliopi. I think we just all need to remember the definition -because there is a definition -of a complete resection when you are dealing with lung cancer. The definition of a complete resection for lung cancer implies, first of all, at the local level, that you have an R0 resection; secondly, to have a complete resection, you must have performed a systematic nodal dissection; and, thirdly, the highest mediastinal lymph node has to be handed off separately and be negative. That is the definition of a complete resection.
Dr Iwata: Yes, I agree with that.
